A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
There is an urgent need for the development of shorter, simpler and more tolerable drugs to treat antibiotic tolerant populations of Mycobacterium tuberculosis. We previously identified a series of hydrazones active against M. tuberculosis. We selected five representative compounds for further analy...
Main Authors: | Shilah A Bonnett, Devon Dennison, Megan Files, Anumita Bajpai, Tanya Parish |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6192558?pdf=render |
Similar Items
-
InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
by: Lindsay Flint, et al.
Published: (2020-01-01) -
In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis
by: Joshua Odingo, et al.
Published: (2017-09-01) -
Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosis
by: Heather H. Wescott, et al.
Published: (2018-10-01) -
A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
by: Julie V Early, et al.
Published: (2019-01-01) -
Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating Mycobacterium abscessus
by: Bryan J. Berube, et al.
Published: (2018-10-01)